# DigitalOcean Holdings, Inc.: financial statements, quarterly

DOCN · NYSE · CIK 1582961 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/docn.md) · [Financials](/companies/docn/financials.md) · [Filings](/companies/docn/filings.md) · [Insiders](/companies/docn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/docn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [177](/filings/0001582961-25-000035.md) | [181](/filings/0001582961-25-000035.md) | [185](/filings/0001582961-25-000087.md) | [192](/filings/0001582961-25-000138.md) | [198](/filings/0001582961-25-000150.md) | [205](/filings/0001582961-25-000035.md) | [211](/filings/0001582961-26-000049.md) | [219](/filings/0001628280-26-052556.md) | [230](/filings/0001582961-25-000150.md) | [242 d](/filings/0001582961-26-000019.md) | [258](/filings/0001582961-26-000049.md) | [281](/filings/0001628280-26-052556.md) |
| Cost of revenue | $m | [73.2](/filings/0001582961-25-000035.md) | [77.6](/filings/0001582961-25-000035.md) | [75.6](/filings/0001582961-25-000087.md) | [78.3](/filings/0001582961-25-000138.md) | [81.9](/filings/0001582961-25-000150.md) | [78.8](/filings/0001582961-25-000035.md) | [81.3](/filings/0001582961-26-000049.md) | [87.8](/filings/0001628280-26-052556.md) | [92.7](/filings/0001582961-25-000150.md) | [100 d](/filings/0001582961-26-000019.md) | [113](/filings/0001582961-26-000049.md) | [127](/filings/0001628280-26-052556.md) |
| Gross profit | $m | [104](/filings/0001582961-25-000035.md) | [103](/filings/0001582961-25-000035.md) | [109](/filings/0001582961-25-000087.md) | [114](/filings/0001582961-25-000138.md) | [117](/filings/0001582961-25-000150.md) | [126](/filings/0001582961-25-000035.md) | [129](/filings/0001582961-26-000049.md) | [131](/filings/0001628280-26-052556.md) | [137](/filings/0001582961-25-000150.md) | [142 d](/filings/0001582961-26-000019.md) | [145](/filings/0001582961-26-000049.md) | [155](/filings/0001628280-26-052556.md) |
| Research and development | $m | [31.7](/filings/0001582961-25-000035.md) | [30.0](/filings/0001582961-25-000035.md) | [32.9](/filings/0001582961-25-000087.md) | [33.0](/filings/0001582961-25-000138.md) | [36.3](/filings/0001582961-25-000150.md) | [40.3](/filings/0001582961-25-000035.md) | [39.6](/filings/0001582961-26-000049.md) | [39.6](/filings/0001628280-26-052556.md) | [38.1](/filings/0001582961-25-000150.md) | [44.3 d](/filings/0001582961-26-000019.md) | [48.8](/filings/0001582961-26-000049.md) | [57.5](/filings/0001628280-26-052556.md) |
| Operating income | $m | [35.5](/filings/0001582961-25-000035.md) | [11.0](/filings/0001582961-25-000035.md) | [11.5](/filings/0001582961-25-000087.md) | [22.3](/filings/0001582961-25-000138.md) | [24.6](/filings/0001582961-25-000150.md) | [32.5](/filings/0001582961-25-000035.md) | [37.6](/filings/0001582961-26-000049.md) | [35.6](/filings/0001628280-26-052556.md) | [44.9](/filings/0001582961-25-000150.md) | [38.8 d](/filings/0001582961-26-000019.md) | [36.6](/filings/0001582961-26-000049.md) | [29.4](/filings/0001628280-26-052556.md) |
| Interest expense | $m | [2.3](/filings/0001582961-23-000068.md) | [2.3](/filings/0001582961-25-000035.md) | [2.3](/filings/0001582961-24-000068.md) | [2.3](/filings/0001582961-25-000138.md) | [2.3](/filings/0001582961-25-000150.md) | [2.2](/filings/0001582961-25-000035.md) | [2.2](/filings/0001582961-26-000049.md) | [2.2](/filings/0001628280-26-052556.md) | [5.0](/filings/0001582961-25-000150.md) | [8.5 d](/filings/0001582961-26-000019.md) | [10.6](/filings/0001582961-26-000049.md) | [7.5](/filings/0001628280-26-052556.md) |
| Income tax | $m | [17.9](/filings/0001582961-25-000035.md) | [(2.4)](/filings/0001582961-25-000035.md) | [0.1](/filings/0001582961-25-000087.md) | [5.7](/filings/0001582961-25-000138.md) | [(3.3)](/filings/0001582961-25-000150.md) | [10.7](/filings/0001582961-25-000035.md) | [3.2](/filings/0001582961-26-000049.md) | [5.4](/filings/0001628280-26-052556.md) | [(68.1)](/filings/0001582961-25-000150.md) | [6.9 d](/filings/0001582961-26-000019.md) | [8.7](/filings/0001582961-26-000049.md) | [(8.3)](/filings/0001628280-26-052556.md) |
| Net income | $m | [19.2](/filings/0001582961-25-000035.md) | [15.9](/filings/0001582961-25-000035.md) | [14.1](/filings/0001582961-25-000087.md) | [19.1](/filings/0001582961-25-000138.md) | [32.9](/filings/0001582961-25-000150.md) | [18.3](/filings/0001582961-25-000035.md) | [38.2](/filings/0001582961-26-000049.md) | [37.0](/filings/0001628280-26-052556.md) | [158](/filings/0001582961-25-000150.md) | [25.7 d](/filings/0001582961-26-000019.md) | [15.8](/filings/0001582961-26-000049.md) | [35.4](/filings/0001628280-26-052556.md) |
| Diluted EPS | $ per share | [0.20](/filings/0001582961-25-000035.md) | [0.17](/filings/0001582961-25-000035.md) | [0.15](/filings/0001582961-25-000087.md) | [0.20](/filings/0001582961-25-000138.md) | [0.33](/filings/0001582961-25-000150.md) | [0.19](/filings/0001582961-25-000035.md) | [0.39](/filings/0001582961-26-000049.md) | [0.39](/filings/0001628280-26-052556.md) | [1.51](/filings/0001582961-25-000150.md) | not reported | [0.15](/filings/0001582961-26-000049.md) | [0.29](/filings/0001628280-26-052556.md) |
| Basic EPS | $ per share | [0.22](/filings/0001582961-25-000035.md) | [0.18](/filings/0001582961-25-000035.md) | [0.16](/filings/0001582961-25-000087.md) | [0.21](/filings/0001582961-25-000138.md) | [0.36](/filings/0001582961-25-000150.md) | [0.20](/filings/0001582961-25-000035.md) | [0.42](/filings/0001582961-26-000049.md) | [0.41](/filings/0001628280-26-052556.md) | [1.74](/filings/0001582961-25-000150.md) | not reported | [0.17](/filings/0001582961-26-000049.md) | [0.34](/filings/0001628280-26-052556.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [79.4](/filings/0001582961-24-000155.md) | [317](/filings/0001582961-25-000035.md) | [419](/filings/0001582961-25-000087.md) | [443](/filings/0001582961-25-000138.md) | [440](/filings/0001582961-25-000150.md) | [428](/filings/0001582961-26-000019.md) | [360](/filings/0001582961-26-000049.md) | [388](/filings/0001628280-26-052556.md) | [237](/filings/0001582961-25-000150.md) | [254](/filings/0001628280-26-052556.md) | [741](/filings/0001582961-26-000049.md) | [767](/filings/0001628280-26-052556.md) |
| Current assets | $m | [471](/filings/0001582961-23-000068.md) | [503](/filings/0001582961-25-000035.md) | [516](/filings/0001582961-24-000068.md) | [544](/filings/0001582961-24-000122.md) | [552](/filings/0001582961-24-000155.md) | [542](/filings/0001582961-26-000019.md) | [479](/filings/0001582961-25-000087.md) | [510](/filings/0001582961-25-000138.md) | [368](/filings/0001582961-25-000150.md) | [427](/filings/0001628280-26-052556.md) | [944](/filings/0001582961-26-000049.md) | [1,018](/filings/0001628280-26-052556.md) |
| Total assets | $m | [1,425](/filings/0001582961-23-000068.md) | [1,461](/filings/0001582961-25-000035.md) | [1,486](/filings/0001582961-24-000068.md) | [1,537](/filings/0001582961-24-000122.md) | [1,526](/filings/0001582961-24-000155.md) | [1,639](/filings/0001582961-26-000019.md) | [1,642](/filings/0001582961-25-000087.md) | [1,720](/filings/0001582961-25-000138.md) | [1,726](/filings/0001582961-25-000150.md) | [1,838](/filings/0001628280-26-052556.md) | [2,570](/filings/0001582961-26-000049.md) | [3,123](/filings/0001628280-26-052556.md) |
| Current liabilities | $m | [184](/filings/0001582961-23-000068.md) | [193](/filings/0001582961-25-000035.md) | [189](/filings/0001582961-24-000068.md) | [220](/filings/0001582961-24-000122.md) | [176](/filings/0001582961-24-000155.md) | [221](/filings/0001582961-26-000019.md) | [198](/filings/0001582961-25-000087.md) | [225](/filings/0001582961-25-000138.md) | [325](/filings/0001582961-25-000150.md) | [619](/filings/0001628280-26-052556.md) | [647](/filings/0001582961-26-000049.md) | [776](/filings/0001628280-26-052556.md) |
| Total liabilities | $m | [1,784](/filings/0001582961-23-000068.md) | [1,775](/filings/0001582961-25-000035.md) | [1,772](/filings/0001582961-24-000068.md) | [1,791](/filings/0001582961-24-000122.md) | [1,738](/filings/0001582961-24-000155.md) | [1,842](/filings/0001582961-26-000019.md) | [1,852](/filings/0001582961-25-000087.md) | [1,895](/filings/0001582961-25-000138.md) | [1,795](/filings/0001582961-25-000150.md) | [1,866](/filings/0001628280-26-052556.md) | [1,683](/filings/0001582961-26-000049.md) | [2,192](/filings/0001628280-26-052556.md) |
| Long-term debt | $m | [1,476](/filings/0001582961-23-000068.md) | [1,478](/filings/0001582961-25-000035.md) | [1,480](/filings/0001582961-24-000068.md) | [1,482](/filings/0001582961-24-000122.md) | [1,483](/filings/0001582961-24-000155.md) | [1,485](/filings/0001582961-26-000019.md) | [1,487](/filings/0001582961-25-000087.md) | [1,489](/filings/0001582961-25-000138.md) | [1,284](/filings/0001582961-25-000150.md) | [971](/filings/0001628280-26-052556.md) | [608](/filings/0001582961-26-000049.md) | [609](/filings/0001628280-26-052556.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001582961-26-000019.md) | not reported | not reported | [9.5](/filings/0001582961-25-000150.md) | [325](/filings/0001628280-26-052556.md) | [311](/filings/0001582961-26-000049.md) | [312](/filings/0001628280-26-052556.md) |
| Shareholders' equity | $m | [(359)](/filings/0001582961-24-000155.md) | [(314)](/filings/0001582961-26-000019.md) | [(286)](/filings/0001582961-25-000138.md) | [(254)](/filings/0001582961-25-000150.md) | [(212)](/filings/0001582961-25-000150.md) | [(203)](/filings/0001628280-26-052556.md) | [(211)](/filings/0001628280-26-052556.md) | [(175)](/filings/0001628280-26-052556.md) | [(69.6)](/filings/0001582961-25-000150.md) | [(28.7)](/filings/0001628280-26-052556.md) | [887](/filings/0001628280-26-052556.md) | [931](/filings/0001628280-26-052556.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [54.1 d](/filings/0001582961-24-000155.md) | [80.5 d](/filings/0001582961-26-000019.md) | [66.7](/filings/0001582961-25-000087.md) | [71.3 d](/filings/0001582961-25-000138.md) | [73.4 d](/filings/0001582961-25-000150.md) | [71.3 d](/filings/0001582961-26-000019.md) | [64.1](/filings/0001582961-26-000049.md) | [92.4 d](/filings/0001628280-26-052556.md) | [95.8 d](/filings/0001582961-25-000150.md) | [57.3 d](/filings/0001582961-26-000019.md) | [46.9](/filings/0001582961-26-000049.md) | [110 d](/filings/0001628280-26-052556.md) |
| Capital expenditure | $m | [20.2 d](/filings/0001582961-24-000155.md) | [52.2 d](/filings/0001582961-26-000019.md) | [43.7](/filings/0001582961-25-000087.md) | [31.9 d](/filings/0001582961-25-000138.md) | [57.4 d](/filings/0001582961-25-000150.md) | [45.3 d](/filings/0001582961-26-000019.md) | [62.0](/filings/0001582961-26-000049.md) | [33.2 d](/filings/0001628280-26-052556.md) | [7.8 d](/filings/0001582961-25-000150.md) | [26.2 d](/filings/0001582961-26-000019.md) | [40.0](/filings/0001582961-26-000049.md) | [41.6 d](/filings/0001628280-26-052556.md) |
| Share repurchases | $m | [106 d](/filings/0001582961-24-000155.md) | [13.5 d](/filings/0001582961-26-000019.md) | [8.8](/filings/0001582961-25-000087.md) | [9.4 d](/filings/0001582961-25-000138.md) | [11.7 d](/filings/0001582961-25-000150.md) | [29.9 d](/filings/0001582961-26-000019.md) | [59.1](/filings/0001582961-26-000049.md) | [20.1 d](/filings/0001628280-26-052556.md) | [2.9 d](/filings/0001582961-25-000150.md) | [0.0 d](/filings/0001582961-26-000019.md) | [0.0](/filings/0001582961-26-000049.md) | [0.0 d](/filings/0001628280-26-052556.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [96.2](/filings/0001582961-25-000035.md) | [103](/filings/0001582961-25-000035.md) | [92.0](/filings/0001582961-25-000035.md) | [93.8](/filings/0001582961-25-000087.md) | [93.8](/filings/0001582961-25-000138.md) | [103](/filings/0001582961-25-000150.md) | [94.4](/filings/0001582961-25-000035.md) | [102](/filings/0001582961-26-000049.md) | [101](/filings/0001628280-26-052556.md) | [106](/filings/0001582961-25-000150.md) | [112](/filings/0001582961-26-000049.md) | [127](/filings/0001628280-26-052556.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 117,579,550 at 2026-07-30, from the cover of the [10-Q filed 2026-08-04](/filings/0001628280-26-052556.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.